Breast Cancer Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

All participants:

• People who identify as female, based on their medical records or self-report
• People who are currently between the ages of 60 and 80
• People who have access to a computer and internet connection
• People who score below 11 on a short memory and thinking test called the Blessed Orientation-Memory-Concentration Test (BOMC) (confirm with trial site)
• People who, if currently taking medications that affect mood or mental health (such as antidepressants or anti-anxiety medications), have been on a stable dose for at least two months before joining
• People who speak English fluently and can hold a reasonable conversation in English, as confirmed by trial staff

Breast cancer survivors (in addition to the above):

• People with a history of stage 0 to 3 breast cancer that was first diagnosed between the ages of 50 and 60
• People who currently have no signs of active cancer (known as "no evidence of disease")

People with no cancer history (control group, in addition to the general criteria above):

• People who have never had breast cancer

Who may not be able to join:

All participants:

• People who have been diagnosed with a condition that affects brain function, such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, dementia, or seizure disorders
• People who have had a stroke or a head injury that caused lasting brain changes, ongoing thinking or memory difficulties affecting daily life, or required cognitive rehabilitation
• People who have been diagnosed with certain serious mental health conditions, including schizophrenia-related disorders, bipolar disorder, schizotypal personality disorder, or substance use disorder
• People with vision or hearing problems severe enough to prevent them from completing the study assessments, even with glasses or hearing aids
• People who take the medications methotrexate or rituximab for rheumatoid arthritis, psoriasis, or Crohn's disease, or cyclophosphamide for lupus
• People who are already taking part in a conflicting research study that involves overlapping brain and thinking assessments (specifically study MSK 18-294)

Breast cancer survivors:

• People whose breast cancer has come back (recurrence)
• People who have had any other type of cancer, except non-melanoma skin cancer (a second breast cancer also makes someone ineligible)
• People whose breast cancer was treated with surgery only, with no other treatments

People with no cancer history (control group):

• People who have previously been treated with radiation, chemotherapy, tamoxifen, or aromatase inhibitors
• People who have had any history of cancer, except non-melanoma skin cancer

Important: Always verify eligibility with the trial site directly before applying.